211 articles — showing all

After the Laser: Four 2025–2026 Cohorts on Fetal Death, Cardiac Recovery, and Membrane Failure in Twin–Twin Transfusion Syndrome
SurgeryEpidemiology & Biostatistics

After the Laser: Four 2025–2026 Cohorts on Fetal Death, Cardiac Recovery, and Membrane Failure in Twin–Twin Transfusion Syndrome

Identical twins who share a placenta can also end up sharing their blood supply, and when that sharing goes wrong one baby is starved while the other is overloaded. Laser surgery inside the womb can separate the two circulations and give both babies a chance. Four studies published in 2025 and 2026…

scientificclinicalfamily
Rebuilding the Second Tier: 21-Deoxycortisol and the Specificity Problem in Congenital Adrenal Hyperplasia Screening
Epidemiology & BiostatisticsHealth Systems & Policy

Rebuilding the Second Tier: 21-Deoxycortisol and the Specificity Problem in Congenital Adrenal Hyperplasia Screening

Every newborn has a few drops of blood taken from the heel in the first days of life, and one of the conditions that blood is checked for is congenital adrenal hyperplasia — a treatable hormone disorder that can be fatal if missed. For decades this particular test has raised far more false alarms…

scientificclinicalfamily
A blood pressure problem that begins in the incubator and is still there at eighteen
Epidemiology & BiostatisticsPharmacology

A blood pressure problem that begins in the incubator and is still there at eighteen

Babies born too early sometimes develop high blood pressure in newborn intensive care, and doctors treat it — but no guideline says which medicine to use. Two 2025 studies fill in opposite ends of the picture: one found a large American hospital reached for the same drug about 61% of the time, out…

scientificclinicalfamily
When the Screen Arrives Before the Drug: Five Years of Nationwide Spinal Muscular Atrophy Screening in Taiwan and a UK Decision Model Built on the Same Uncertainties
Genetics & GenomicsHealth Systems & Policy

When the Screen Arrives Before the Drug: Five Years of Nationwide Spinal Muscular Atrophy Screening in Taiwan and a UK Decision Model Built on the Same Uncertainties

Spinal muscular atrophy is a rare inherited condition that weakens the nerves controlling movement and breathing, and it was once the most common genetic cause of death in babies. Three medicines can now change its course — but they work far better when given before a baby shows any symptoms. That…

scientificclinicalfamily